Ischaemia with No Obstructive Coronary Artery disease (INOCA) 2025 will offer an in-depth exploration of Coronary Microvascular Dysfunction and is supported by the National Institute for Health and Care Research (NIHR) British Heart Foundation (BHF) Cardiovascular Partnership, the NIHR HealthTech Research Centre (HRC) in Cardiovascular and Respiratory Medicine, and King's College London.
INOCA represents a critical and emerging frontier in cardiovascular medicine, revealing the complexity of myocardial ischaemia beyond traditional models focused on obstructive coronary disease. The 2025 meeting will serve as a vital forum for clinicians, scientists, industry partners, and regulators to advance the understanding, diagnosis, and treatment of this under-recognised condition, drawing on international expertise to address a pressing clinical challenge.
The NIHR-BHF Cardiovascular Partnership brings together academia, clinical researchers, charities, and industry stakeholders to accelerate translational research, foster innovation, and drive meaningful improvements in patient care. It actively supports collaborative projects targeting unmet needs across the cardiovascular spectrum, ensuring rapid translation of discoveries from bench to bedside.
A dedicated microvascular disease workstream within the Partnership, led by Professors Divaka Perera and Amedeo Chiribiri of King's College London, plays a central role in advancing research and innovation in coronary microvascular dysfunction-one of the central themes of INOCA 2025.
The NIHR HealthTech Research Centre (HRC) in Cardiovascular and Respiratory Medicine, under the leadership of Professor Chiribiri (Director) and Professor Perera (Theme Lead for Cardiovascular Diseases in Adults), is committed to addressing major challenges in cardiovascular and respiratory health. Hosted by Guy's and St Thomas' NHS Foundation Trust and King's College London, the HRC is a collaborative research hub that integrates state-of-the-art scientific discovery with clinical expertise and strong industry engagement.
The HRC works closely with the London Institute for Healthcare Engineering (LIHE), which plays a key role in facilitating partnerships with industry and supporting the co-development of innovative technologies.
By supporting INOCA 2025, these collaborative initiatives reaffirm their commitment to addressing complex and often overlooked cardiovascular conditions, ensuring that cutting-edge science is translated into tangible improvements in care for patients living with ischaemic heart disease without obstructive coronary lesions.
